Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer Pain

NCT06897917 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.

NCT NCT06897917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06897917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer Pain
Lead sponsor
Henan Cancer Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
April 30, 2025
Completion date
December 31, 2025
Enrollment
203 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid-induced constipation, pain cancer